Perfect Pitch

Building on the success of the first Perfect Pitch event run at the BioTrinity’s 10th anniversary edition in 2016, the 2017 event was also a great success.  The standard was high across the field of competitors with informative and entertaining performances and it was an enjoyable finale to the conference.

How Perfect Pitch works

  • About 10 company CEO’s deliver 3 minute investment pitches to half a dozen seasoned investors in an intense 60 minutes
  • The panel gave feedback on the pitches
  • The top picks from the first round were invited to pitch in the final

The Judging Panel 2017

Panel chair: 

  • Kate Bingham, Managing Partner, SV Life Sciences (UK) 

Panel: 

  • Maina Bhaman, Director of Healthcare Investments, Touchstone Innovations (UK)
  • Kreske Nickelsen, General Partner & Chief Executive Officer, Joint Polish Investment Fund (Poland) 
  • Graeme Martin, Founder, HatchBox Bioconsulting LLC (US) 
  • Naveed Siddiqi, Partner, Edmond de Rothschild Investment Partners (UK/France)
  • Andrew McLean, ‎Lead Life Sciences Investor,  ‎Oxford Sciences Innovation (UK) 
  • Detlev Mennerich, Director and Investment Manager, Boehringer Ingelheim Ventures (Germany)

The Competitors 2017

  • Bert Rutter (CSO), Auspherix
  • Caroline Barelle (CEO), Elasmogen
  • Charles Potter (CEO), Unguis
  • Ivan Petyaev (CEO), Lycotec
  • Michael Scherz (CEO), Metys Pharmaceuticals AG
  • Mike Karim (CEO), Oxford Endovascular
  • Paul Colbon (CEO), Liverpool Chirochem
  • Roy Farfara (CSO), TrioxNano
  • Tim Mitchell (CEO), Sareum
  • Will Dracup (CEO), Biosignatures

 Perfect Pitch 2017 winner 

  • Dr Mike Karim, CEO, Oxford Endovascular

Contact us

To discuss Company Showcases, Later Stage Showcases and Perfect Pitch opportunities contact:

Jonathan Rohll, Analyst and EU Project Manager
Email:  jonathan.rohll@obn.org.uk or tel: +44 (0)1235 420 877